Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
Toho Holdings Co Ltd
8129Toho Holdings Co., Ltd. engages in the wholesale distribution of pharmaceutical products in Japan. The company operates in four segments: Pharmaceutical Wholesale Business, Dispensing Pharmacy Business, Pharmaceutical Manufacturing and Sales Business, and Other Peripheral Businesses. It sells prescription pharmaceuticals, test reagents, and testing equipment, as well as provides support services, including the development and sale of customer support systems, assistance in the start-up of medical institutions and pharmacies, management consulting services, medical support, and personnel recruitment. The company also engages in dispensing pharmacy business; manufacture and sale of generic drugs; and site management organization business that assists various medical institutions with clinical trials under contract, as well as sells software to medical institutions. In addition, it provides various customer support systems, including ENIF, an information terminal for pharmaceutical ordering; ENI-Pharmacy, a support system for the separation of dispensing and prescribing functions; LXMATE HeLios a medical care appointment system; KAITOS, an online medical consultation and medication guidance system; ENIFwin, an inventory control system for large hospitals; ENIFvoice SP/ ENIFvoice SP + A/ ENIFvoice Core, a supporting system for electronic medication history recording with voice recognition; and ENIF Nurse, an operation support terminal for home-visit nurses; and logistics systems, as well as maintenance services related to customer support systems. The company was incorporated in 1948 and is headquartered in Tokyo, Japan. Address: 5-2-1, Daizawa, Tokyo, Japan, 155-8655
Analytics
Zielpreis von Wall Street
695 541.72 JPYKGV
17.8222Dividendenrendite
0.69 %Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen 8129
Dividenden-Analyse 8129
Dividendenwachstum über 5 Jahre
-40 %Kontinuierliches Wachstum
1 JahrAusschüttungsquote 5-Jahres-Durchschnitt
18 %Verlauf der Dividende 8129
Bewertung der Aktie 8129
Finanzen 8129
Ergebnisse | 2019 | Dynamik |